TY  - JOUR

T1  - Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA‐MI Trial

JO  - Journal of the American Heart Association

UR  - https://doi.org/10.1161/jaha.124.040327

PY  - 2025/07/29

AU  - Storey RF

AU  - Deanfield J

AU  - James S

AU  - Ajjan RA

AU  - Eriksson N

AU  - Erlinge D

AU  - de Belder M

AU  - Gale CP

AU  - Zaman A

AU  - Hofmann R

AU  - Mellbin L et al

ED  - 

DO  - DOI: 10.1161/jaha.124.040327

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 14

IS  - 15

Y2  - 2025/10/06

ER  -